Cardinal Health
740 hedge funds and large institutions have $11.6B invested in Cardinal Health in 2020 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 254 increasing their positions, 302 reducing their positions, and 89 closing their positions.
1.72% less ownership
Funds ownership: 86.53% → 84.81% (-1.7%)
3% less funds holding
Funds holding: 765 → 740 (-25)
12% less capital invested
Capital invested by funds: $13.2B → $11.6B (-$1.56B)
16% less repeat investments, than reductions
Existing positions increased: 254 | Existing positions reduced: 302
22% less first-time investments, than exits
New positions opened: 69 | Existing positions closed: 89
23% less call options, than puts
Call options by funds: $109M | Put options by funds: $142M
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$84.8M |
| 2 |
State of Tennessee, Department of Treasury
Nashville,
Tennessee
|
+$51.7M |
| 3 |
D.E. Shaw & Co
New York
|
+$49.1M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$45.5M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$42.7M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$172M |
| 2 |
PP
Prudential plc
London, England,
United Kingdom
|
-$114M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$76.5M |
| 4 |
Bank of New York Mellon
New York
|
-$71.3M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$45.2M |
CAH Hedge Fund Activity: Q3 2020 in Review
740 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q3 2020, worth a combined $11.6B — down 12% from $13.2B a quarter earlier.
Sellers outnumbered buyers: 89 funds closed out of CAH and 69 opened new positions — a net loss of 20 holders — while 302 trimmed existing stakes and 254 added.
The largest buyer was Citadel Advisors, adding an estimated $84.8M. The largest seller was Ameriprise, cutting an estimated $172M.
- 740 institutional investors held Cardinal Health (CAH) as of Q3 2020, down from 765 in Q2 2020.
- Funds reported $11.6B of Cardinal Health stock for Q3 2020, down 12% quarter-over-quarter.
- 69 funds opened new Cardinal Health positions in Q3 2020 and 89 closed out, a net change of -20 holders.
- The largest Cardinal Health buyer in Q3 2020 was Citadel Advisors, an estimated $84.8M added.
- The largest Cardinal Health seller in Q3 2020 was Ameriprise, an estimated $172M sold.
Based on aggregated 13F filings for Q3 2020.